Industrial Effluent Treatment: Biological Approaches

Industrial effluents are far more diverse than municipal wastewater, varying in composition, strength, temperature, pH, and toxicity across industries and even within a single facility over time. Textile wastewater contains dyes, salts, and auxiliary chemicals; pharmaceutical wastewater contains active ingredients, solvents, and high organic loads; dairy wastewater contains fats, proteins, and lactose; pulp and paper wastewater contains lignin, hemicellulose, and chlorinated organics; refinery wastewater contains oil, phenols, and sulfides. Each requires tailored treatment approaches.

Biological treatment is often the most cost-effective approach for the organic fraction of industrial effluents, but it must be integrated with appropriate pre-treatment (screening, equalization, neutralization, sometimes chemical oxidation) and post-treatment (polishing, disinfection, sometimes advanced oxidation) to meet discharge standards. The design must account for the specific characteristics of the effluent, including the presence of inhibitory compounds that may require dilution, acclimation, or specialized treatment.

Hrisana Journal welcomes research across all aspects of industrial effluent treatment — from fundamental studies of pollutant biodegradation through process development and full-scale implementation. Our interdisciplinary scope reflects the integrated nature of effective industrial wastewater management.

Textile wastewater is characterized by high colour (from dyes), high dissolved solids (from salts), variable pH, and moderate to high organic load (from sizing agents, surfactants, and other auxiliaries). Azo dyes — the largest dye class — are recalcitrant to aerobic biodegradation because the azo bond cannot be cleaved aerobically by most bacteria. Anaerobic treatment reduces the azo bond, producing aromatic amines that may be toxic and require further aerobic treatment for complete mineralization.

Combined anaerobic-aerobic treatment is therefore the typical biological configuration for textile wastewater. The anaerobic stage decolorizes the effluent by cleaving azo bonds; the aerobic stage mineralizes the resulting aromatic amines and removes remaining BOD. Various reactor configurations — UASB, anaerobic filter, fluidized bed — are used for the anaerobic stage; activated sludge, sequencing batch reactors, or membrane bioreactors are used for the aerobic stage. Performance depends on dye type and concentration, salt concentration, and the presence of other auxiliaries.

Advanced treatment may be needed for colour polishing and removal of recalcitrant organics. Oxidative processes (Fenton, photo-Fenton, ozonation, photocatalysis) can break down residual colour and organics. Adsorption on activated carbon removes a broad spectrum of contaminants. Membrane processes (nanofiltration, reverse osmosis) can produce water suitable for reuse in the mill. The selection of advanced treatment depends on discharge standards or reuse requirements and on the specific wastewater composition.

Pharmaceutical wastewater is characterized by very high organic load (COD often >10,000 mg/L), the presence of active pharmaceutical ingredients (APIs) that may be biologically active or inhibitory, solvents, and reaction by-products. The variability in composition — batch processes produce different effluents at different times — adds complexity. Biological treatment is typically the core technology, but pre-treatment (solvent recovery, chemical oxidation of inhibitory compounds) and post-treatment (polishing, removal of residual APIs) are often required.

Anaerobic treatment is particularly suitable for high-strength pharmaceutical wastewater, achieving high COD removal with low sludge production and energy recovery. UASB and EGSB reactors are widely deployed. However, some APIs and solvents are inhibitory to methanogenic archaea, requiring pre-treatment or dilution. Anaerobic treatment is typically followed by aerobic polishing for removal of residual organics and nitrogen. Nitrification may be inhibited by some pharmaceuticals, requiring longer sludge ages or biofilm systems.

Removal of residual APIs is a particular concern because of their biological activity at very low concentrations. Conventional biological treatment achieves variable and often incomplete removal of pharmaceuticals. Advanced treatment — activated carbon adsorption, advanced oxidation (ozone, UV/hydrogen peroxide), membrane processes (reverse osmosis) — may be needed to meet discharge standards or enable water reuse. The selection and design of these processes depends on the specific APIs present, their concentrations, and the treatment objectives.

Dairy wastewater contains fats, proteins, and lactose, with BOD typically 1,000-5,000 mg/L. The high biodegradability of the organics makes biological treatment very effective. Anaerobic treatment (UASB, EGSB) achieves high COD removal with biogas production; aerobic polishing removes residual organics and nutrients. Fats can cause operational problems (foaming, scum formation, coating of biomass) and may require pre-treatment by dissolved air flotation or grease separation. Nutrient addition (nitrogen, phosphorus) may be needed because dairy wastewater is nutrient-deficient relative to its organic load.

Pulp and paper wastewater contains lignin, hemicellulose, extractives, and chlorinated organics (from bleaching, in mills that use chlorine-based bleaching). The high lignin content and presence of inhibitory extractives require careful management. Anaerobic treatment is effective for the readily biodegradable fraction but leaves recalcitrant lignin-derived compounds. Aerobic treatment, particularly with fungi that can degrade lignin, can reduce colour and recalcitrant organics. Closure of water circuits and process modifications (elemental chlorine-free bleaching, totally chlorine-free bleaching) have reduced the load of chlorinated organics, but colour and toxicity remain concerns.

Refinery wastewater contains oil, phenols, sulfides, ammonia, and various hydrocarbons. Pre-treatment by API separators, dissolved air flotation, and sometimes sour water strippers removes free oil and sulfides. Biological treatment, typically in activated sludge or aerated lagoon systems, removes dissolved organics, phenols, and ammonia. The presence of inhibitory compounds (sulfides, heavy metals) requires careful process management. Post-treatment may include polishing for removal of residual organics and dissolved solids, particularly if water reuse is targeted.

Innovation in industrial effluent treatment spans several directions. Membrane bioreactors enable high-quality effluent suitable for reuse, with smaller footprint than conventional systems. Anaerobic membrane bioreactors extend anaerobic treatment to more dilute wastewaters while producing biogas. Advanced oxidation processes — particularly catalytic processes and electrochemical oxidation — offer new approaches to recalcitrant organics. Resource recovery — water reuse, nutrient recovery, biopolymer production — transforms wastewater from a cost to a value stream.

Industrial symbiosis approaches use the wastewater from one facility as a feedstock for another, reducing freshwater demand and waste discharge. The integration of industrial effluent treatment with municipal systems — co-treatment of compatible industrial and municipal wastewater — can improve economics and performance for both. Process control, supported by online sensors and machine learning models, enables optimization that would be impossible with manual control.

Hrisana Journal welcomes submissions across all aspects of industrial effluent treatment. Manuscripts should clearly characterize the wastewater (industry source, composition, variability), describe the treatment process in sufficient detail for reproduction, report quantitative performance data, and discuss the implications for full-scale implementation. Visit our Submit Manuscript page to begin your submission, or review our Author Guidelines for preparation requirements.